Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Substrate specificity of new methyl-directed DNA endonuclease GlaI.

Tarasova GV, Nayakshina TN, Degtyarev SK.

BMC Mol Biol. 2008 Jan 15;9:7. doi: 10.1186/1471-2199-9-7.

2.

A universal competitive fluorescence polarization activity assay for S-adenosylmethionine utilizing methyltransferases.

Graves TL, Zhang Y, Scott JE.

Anal Biochem. 2008 Feb 15;373(2):296-306. Epub 2007 Sep 29.

3.

Kinetic analysis of Yersinia pestis DNA adenine methyltransferase activity using a hemimethylated molecular break light oligonucleotide.

Wood RJ, Maynard-Smith MD, Robinson VL, Oyston PC, Titball RW, Roach PL.

PLoS One. 2007 Aug 29;2(8):e801.

4.

UHRF1 plays a role in maintaining DNA methylation in mammalian cells.

Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE.

Science. 2007 Sep 21;317(5845):1760-4. Epub 2007 Aug 2.

5.

The epigenomics of cancer.

Jones PA, Baylin SB.

Cell. 2007 Feb 23;128(4):683-92. Review.

6.

Hairpin fluorescence DNA probe for real-time monitoring of DNA methylation.

Li J, Yan H, Wang K, Tan W, Zhou X.

Anal Chem. 2007 Feb 1;79(3):1050-6.

PMID:
17263334
7.

Reversible inactivation of the CG specific SssI DNA (cytosine-C5)-methyltransferase with a photocleavable protecting group.

Rathert P, Raskó T, Roth M, Slaska-Kiss K, Pingoud A, Kiss A, Jeltsch A.

Chembiochem. 2007 Jan 22;8(2):202-7.

PMID:
17195251
8.

Regulation of DNA methyltransferase 1.

Spada F, Rothbauer U, Zolghadr K, Schermelleh L, Leonhardt H.

Adv Enzyme Regul. 2006;46:224-34. Epub 2006 Jul 20. Review. No abstract available.

PMID:
16859735
9.

Selective inhibitors of bacterial DNA adenine methyltransferases.

Mashhoon N, Pruss C, Carroll M, Johnson PH, Reich NO.

J Biomol Screen. 2006 Aug;11(5):497-510. Epub 2006 Jun 7.

PMID:
16760373
10.
11.

DNA cytosine C5 methyltransferase Dnmt1: catalysis-dependent release of allosteric inhibition.

Svedruzić ZM, Reich NO.

Biochemistry. 2005 Jul 12;44(27):9472-85.

PMID:
15996102
12.

Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.

Kaminskas E, Farrell A, Abraham S, Baird A, Hsieh LS, Lee SL, Leighton JK, Patel H, Rahman A, Sridhara R, Wang YC, Pazdur R; FDA.

Clin Cancer Res. 2005 May 15;11(10):3604-8.

13.

A nonradioactive DNA methyltransferase assay adaptable to high-throughput screening.

Woo YH, Rajagopalan PT, Benkovic SJ.

Anal Biochem. 2005 May 15;340(2):336-40.

PMID:
15840507
14.

Dam methylation: coordinating cellular processes.

Løbner-Olesen A, Skovgaard O, Marinus MG.

Curr Opin Microbiol. 2005 Apr;8(2):154-60. Review.

PMID:
15802246
15.

The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites.

Hermann A, Goyal R, Jeltsch A.

J Biol Chem. 2004 Nov 12;279(46):48350-9. Epub 2004 Aug 31.

16.

An enzyme-coupled colorimetric assay for S-adenosylmethionine-dependent methyltransferases.

Hendricks CL, Ross JR, Pichersky E, Noel JP, Zhou ZS.

Anal Biochem. 2004 Mar 1;326(1):100-5.

PMID:
14769341
17.

Forming facultative heterochromatin: silencing of an X chromosome in mammalian females.

Chow JC, Brown CJ.

Cell Mol Life Sci. 2003 Dec;60(12):2586-603. Review.

PMID:
14685685
18.

Mammalian DNA (cytosine-5) methyltransferases and their expression.

Pradhan S, Esteve PO.

Clin Immunol. 2003 Oct;109(1):6-16. Review.

PMID:
14585271
19.

The occurrence of 6-methylaminopurine in deoxyribonucleic acids.

DUNN DB, SMITH JD.

Biochem J. 1958 Apr;68(4):627-36. No abstract available.

20.

The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity.

Hermann A, Schmitt S, Jeltsch A.

J Biol Chem. 2003 Aug 22;278(34):31717-21. Epub 2003 Jun 6.

Supplemental Content

Support Center